Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets

Type 1 diabetes (T1D) is an autoimmune disease caused by the immune system attacking and destroying insulin-producing β cells in the pancreas. Islet transplantation is becoming one of the most promising therapies for T1D patients. However, its clinical use is limited by substantial cell loss after i...

Full description

Bibliographic Details
Main Authors: Yannan Shi, Ying-Zheng Zhao, Zhikai Jiang, Zeqing Wang, Qian Wang, Longfa Kou, Qing Yao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.923241/full
_version_ 1818518262535684096
author Yannan Shi
Ying-Zheng Zhao
Zhikai Jiang
Zeqing Wang
Qian Wang
Longfa Kou
Qing Yao
author_facet Yannan Shi
Ying-Zheng Zhao
Zhikai Jiang
Zeqing Wang
Qian Wang
Longfa Kou
Qing Yao
author_sort Yannan Shi
collection DOAJ
description Type 1 diabetes (T1D) is an autoimmune disease caused by the immune system attacking and destroying insulin-producing β cells in the pancreas. Islet transplantation is becoming one of the most promising therapies for T1D patients. However, its clinical use is limited by substantial cell loss after islet infusion, closely related to immune reactions, including instant blood-mediated inflammatory responses, oxidative stress, and direct autoimmune attack. Especially the grafted islets are not only exposed to allogeneic immune rejection after transplantation but are also subjected to an autoimmune process that caused the original disease. Due to the development and convergence of expertise in biomaterials, nanotechnology, and immunology, protective strategies are being investigated to address this issue, including exploring novel immune protective agents, encapsulating islets with biomaterials, and searching for alternative implantation sites, or co-transplantation with functional cells. These methods have significantly increased the survival rate and function of the transplanted islets. However, most studies are still limited to animal experiments and need further studies. In this review, we introduced the immunological challenges for islet graft and summarized the recent developments in immune-protective strategies to improve the outcomes of islet transplantation.
first_indexed 2024-12-11T01:07:35Z
format Article
id doaj.art-ab4c5a95f6424b3f891bd747f8bb73a5
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-11T01:07:35Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-ab4c5a95f6424b3f891bd747f8bb73a52022-12-22T01:26:08ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-07-011310.3389/fimmu.2022.923241923241Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted IsletsYannan Shi0Ying-Zheng Zhao1Zhikai Jiang2Zeqing Wang3Qian Wang4Longfa Kou5Qing Yao6School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, ChinaSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, ChinaThe Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, ChinaSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, ChinaThe Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, ChinaSchool of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, ChinaType 1 diabetes (T1D) is an autoimmune disease caused by the immune system attacking and destroying insulin-producing β cells in the pancreas. Islet transplantation is becoming one of the most promising therapies for T1D patients. However, its clinical use is limited by substantial cell loss after islet infusion, closely related to immune reactions, including instant blood-mediated inflammatory responses, oxidative stress, and direct autoimmune attack. Especially the grafted islets are not only exposed to allogeneic immune rejection after transplantation but are also subjected to an autoimmune process that caused the original disease. Due to the development and convergence of expertise in biomaterials, nanotechnology, and immunology, protective strategies are being investigated to address this issue, including exploring novel immune protective agents, encapsulating islets with biomaterials, and searching for alternative implantation sites, or co-transplantation with functional cells. These methods have significantly increased the survival rate and function of the transplanted islets. However, most studies are still limited to animal experiments and need further studies. In this review, we introduced the immunological challenges for islet graft and summarized the recent developments in immune-protective strategies to improve the outcomes of islet transplantation.https://www.frontiersin.org/articles/10.3389/fimmu.2022.923241/fullislet transplantationimmune reactionsbiomaterialsislet encapsulationcell therapy
spellingShingle Yannan Shi
Ying-Zheng Zhao
Zhikai Jiang
Zeqing Wang
Qian Wang
Longfa Kou
Qing Yao
Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets
Frontiers in Immunology
islet transplantation
immune reactions
biomaterials
islet encapsulation
cell therapy
title Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets
title_full Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets
title_fullStr Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets
title_full_unstemmed Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets
title_short Immune-Protective Formulations and Process Strategies for Improved Survival and Function of Transplanted Islets
title_sort immune protective formulations and process strategies for improved survival and function of transplanted islets
topic islet transplantation
immune reactions
biomaterials
islet encapsulation
cell therapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.923241/full
work_keys_str_mv AT yannanshi immuneprotectiveformulationsandprocessstrategiesforimprovedsurvivalandfunctionoftransplantedislets
AT yingzhengzhao immuneprotectiveformulationsandprocessstrategiesforimprovedsurvivalandfunctionoftransplantedislets
AT zhikaijiang immuneprotectiveformulationsandprocessstrategiesforimprovedsurvivalandfunctionoftransplantedislets
AT zeqingwang immuneprotectiveformulationsandprocessstrategiesforimprovedsurvivalandfunctionoftransplantedislets
AT qianwang immuneprotectiveformulationsandprocessstrategiesforimprovedsurvivalandfunctionoftransplantedislets
AT longfakou immuneprotectiveformulationsandprocessstrategiesforimprovedsurvivalandfunctionoftransplantedislets
AT qingyao immuneprotectiveformulationsandprocessstrategiesforimprovedsurvivalandfunctionoftransplantedislets